Trial Profile
Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNA.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2013
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Entecavir
- Indications Hepatitis B
- Focus Therapeutic Use
- 23 Aug 2013 New trial record